BACKGROUND: Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysis-dependent CKD (NDD-CKD). METHODS: We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of pre-dialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. RESULTS: Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus > or =22 mmol/L: 1.33 (1.05-1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 26-29 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. CONCLUSIONS: Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.
BACKGROUND:Metabolic acidosis, usually manifested by low serum bicarbonate level, is common in chronic kidney disease (CKD) and appears to be associated with higher mortality in dialysis patients. It is not known whether a similar association is present in patients with non-dialysis-dependent CKD (NDD-CKD). METHODS: We used multivariable-adjusted Cox models to examine the association between baseline and time-variable serum bicarbonate (measured as total CO2) with the outcomes of all-cause mortality and the composite of pre-dialysis mortality or end-stage renal disease in 1240 male patients with moderate and advanced NDD-CKD. RESULTS: Serum bicarbonate showed a significant U-shaped association with all-cause mortality, with the highest mortality rate observed in patients with baseline serum bicarbonate levels <22 mmol/L [multivariable-adjusted hazard ratio (95% confidence interval) for patients with serum bicarbonate <22 mmol/L versus > or =22 mmol/L: 1.33 (1.05-1.69), P = 0.02] and the lowest mortality observed in patients with baseline serum bicarbonate of 26-29 mmol/L. The associations between lower serum bicarbonate level and mortality were more accentuated in subgroups of patients with better nutritional status and lower inflammation. CONCLUSIONS: Both lower and higher serum bicarbonates are associated with increased all-cause mortality in patients with moderate and advanced NDD-CKD. Clinical trials are needed to determine if therapeutic interventions aimed at optimizing serum bicarbonate can result in improved outcomes in this population.
Authors: J P Kooman; N E Deutz; P Zijlmans; A van den Wall Bake; P G Gerlag; J P van Hooff; K M Leunissen Journal: Nephrol Dial Transplant Date: 1997-11 Impact factor: 5.992
Authors: K A Graham; D Reaich; S M Channon; S Downie; E Gilmour; J Passlick-Deetjen; T H Goodship Journal: Kidney Int Date: 1996-05 Impact factor: 10.612
Authors: Todd H Driver; Michael G Shlipak; Ronit Katz; Leonard Goldenstein; Mark J Sarnak; Andrew N Hoofnagle; David S Siscovick; Bryan Kestenbaum; Ian H de Boer; Joachim H Ix Journal: Am J Kidney Dis Date: 2014-06-18 Impact factor: 8.860
Authors: Leonard Goldenstein; Todd H Driver; Linda F Fried; Dena E Rifkin; Kushang V Patel; Robert H Yenchek; Tamara B Harris; Stephen B Kritchevsky; Anne B Newman; Mark J Sarnak; Michael G Shlipak; Joachim H Ix Journal: Am J Kidney Dis Date: 2014-06-18 Impact factor: 8.860
Authors: Sankar D Navaneethan; Jesse D Schold; Susana Arrigain; Stacey E Jolly; Edgard Wehbe; Rupesh Raina; James F Simon; Titte R Srinivas; Anil Jain; Martin J Schreiber; Joseph V Nally Journal: Clin J Am Soc Nephrol Date: 2011-09-01 Impact factor: 8.237
Authors: Lyndsay A Harshman; Amy J Kogon; Matthew B Matheson; Rebecca J Johnson; Shlomo Shinnar; Arlene C Gerson; Bradley A Warady; Susan L Furth; Stephen R Hooper; Marc B Lande Journal: Pediatr Nephrol Date: 2020-04-15 Impact factor: 3.714
Authors: Marion Vallet; Marie Metzger; Jean-Philippe Haymann; Martin Flamant; Cédric Gauci; Eric Thervet; Jean-Jacques Boffa; François Vrtovsnik; Marc Froissart; Bénédicte Stengel; Pascal Houillier Journal: Kidney Int Date: 2015-03-11 Impact factor: 10.612
Authors: Jessica B Kendrick; Leila Zelnick; Michel B Chonchol; David Siscovick; Andrew N Hoofnagle; Joachim H Ix; Mark Sarnak; Michael G Shlipak; Bryan Kestenbaum; Ian H de Boer Journal: Am J Nephrol Date: 2016-12-10 Impact factor: 3.754
Authors: Rasheed A Balogun; Emaad M Abdel-Rahman; Seki A Balogun; Evan H Lott; Jun Ling Lu; Sandra M Malakauskas; Jennie Z Ma; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Clin J Am Soc Nephrol Date: 2012-08-16 Impact factor: 8.237